Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HCXY
Upturn stock ratingUpturn stock rating

Hercules Capital Inc (HCXY)

Upturn stock ratingUpturn stock rating
$24.71
Delayed price
Profit since last BUY-1.12%
upturn advisory
WEAK BUY
BUY since 36 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/07/2025: HCXY (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -7.98%
Avg. Invested days 46
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/07/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.32B USD
Price to earnings Ratio 19.41
1Y Target Price -
Price to earnings Ratio 19.41
1Y Target Price -
Volume (30-day avg) 1175
Beta -
52 Weeks Range 23.01 - 25.57
Updated Date 04/6/2025
52 Weeks Range 23.01 - 25.57
Updated Date 04/6/2025
Dividends yield (FY) 4.91%
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE 19.41
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Hercules Capital Inc

stock logo

Company Overview

overview logo History and Background

Hercules Capital, Inc. was founded in December 2003. It is a specialty finance company focused on providing financing to venture capital-backed companies in technology, life sciences, and sustainable and renewable technology sectors. It has evolved from a start-up lender to a publicly traded BDC.

business area logo Core Business Areas

  • Venture Debt: Providing senior secured loans, often alongside equity investments from venture capital firms, to growing companies in technology and life sciences.
  • Equity Investments: Making strategic equity investments in its portfolio companies, typically as part of the venture debt financing.
  • Other Investments: Holding warrants and other equity-related securities.

leadership logo Leadership and Structure

Hercules Capital is led by Scott Bluestein (CEO). It operates as a business development company (BDC), regulated under the Investment Company Act of 1940. The organizational structure includes various departments for origination, underwriting, portfolio management, and finance.

Top Products and Market Share

overview logo Key Offerings

  • Venture Debt Financing: Hercules Capital's primary offering is venture debt, typically senior secured loans ranging from $5 million to $40 million. They focus on later stage venture backed companies. Market share data is not publicly available; however, Hercules Capital is considered a leading provider in this niche. Competitors include Silicon Valley Bank (now part of First Citizens BancShares), Western Technology Investment, and Bridge Bank.
  • Equity Co-Investments: In addition to debt, Hercules Capital makes smaller equity investments alongside venture capital firms. Revenue from equity co-investments is smaller and more volatile. The strategic rationale is to increase yield and upside potential from its portfolio companies. Competitors are venture capital firms that may compete to make direct equity investment.

Market Dynamics

industry overview logo Industry Overview

The venture debt industry caters to venture-backed companies that require growth capital beyond equity financing. It is influenced by venture capital funding levels, interest rates, and the overall economic environment.

Positioning

Hercules Capital is a leader in the venture debt space, known for its expertise in technology and life sciences lending. Its competitive advantages include a strong origination network, deep understanding of the venture ecosystem, and ability to provide flexible financing solutions.

Total Addressable Market (TAM)

The TAM is estimated to be in the billions of dollars, dependent on venture capital activity. Hercules Capital is positioned well to capture a significant portion of the venture debt market, based on its leading brand and established relationships.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition in the venture debt market
  • Experienced management team with expertise in technology and life sciences
  • Established relationships with venture capital firms
  • Disciplined underwriting process
  • Publicly traded BDC structure provides access to capital

Weaknesses

  • Concentration in technology and life sciences sectors
  • Reliance on venture capital funding environment
  • Higher risk profile compared to traditional lenders
  • Sensitivity to interest rate fluctuations
  • Potentially subject to increased regulatory scrutiny.

Opportunities

  • Expansion into new technology and life sciences sub-sectors
  • Increased demand for venture debt as venture capital funding becomes more selective
  • Strategic acquisitions of smaller venture debt providers
  • Developing new financing products and services
  • Expanding its presence to additional geographies.

Threats

  • Economic downturn leading to decreased venture capital funding
  • Increased competition from other venture debt providers
  • Rising interest rates increasing borrowing costs
  • Deterioration in credit quality of portfolio companies
  • Changes in regulations affecting BDCs

Competitors and Market Share

competitor logo Key Competitors

  • SVB
  • OXSQ
  • TPVG
  • PSEC

Competitive Landscape

Hercules Capital is a leading venture debt provider with a strong reputation and established relationships. Its competitive advantages include its expertise in technology and life sciences lending, disciplined underwriting process, and ability to provide flexible financing solutions. SVB's exit leaves a hole.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Hercules Capital has demonstrated growth in its loan portfolio and net investment income over the past years, driven by increasing demand for venture debt and its successful origination efforts.

Future Projections: Future growth is expected to be driven by continued demand for venture debt in the technology and life sciences sectors. Analyst estimates vary based on the economic environment and venture capital funding levels.

Recent Initiatives: Recent initiatives include expanding its lending platform, focusing on larger loan sizes, and diversifying its portfolio.

Summary

Hercules Capital is a prominent player in the venture debt market, capitalizing on the funding needs of innovative companies. Its established relationships and sector expertise fuel its success. The company's exposure to the technology and life sciences sectors presents both opportunity and risk. Navigating interest rate fluctuations and competition within the venture debt space are crucial for sustained growth.

Similar Companies

MAINratingrating

Main Street Capital Corporation

$51.48
Mid-Cap Stock
0%
PASS

MAINratingrating

Main Street Capital Corporation

$51.48
Mid-Cap Stock
0%
PASS

OXSQratingrating

Oxford Square Capital Corp

$2.8
Small-Cap Stock
6.06%
Consider higher Upturn Star rating
BUY since 24 days

OXSQratingrating

Oxford Square Capital Corp

$2.8
Small-Cap Stock
BUY since 24 days
6.06%
Consider higher Upturn Star rating

PSECratingrating

Prospect Capital Corporation

$3.52
Small-Cap Stock
0%
PASS

PSECratingrating

Prospect Capital Corporation

$3.52
Small-Cap Stock
0%
PASS

TPVGratingrating

Triplepoint Venture Growth BDC Corp

$5.76
Small-Cap Stock
0%
PASS

TPVGratingrating

Triplepoint Venture Growth BDC Corp

$5.76
Small-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • Company filings
  • Analyst reports
  • Industry publications

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and based on available data.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Hercules Capital Inc

Exchange NYSE
Headquaters -
IPO Launch date 2018-09-27
CEO -
Sector Financials
Industry Investment Banking & Investment Services
Full time employees 67
Website
Full time employees 67
Website

Hercules Capital, Inc., formerly known as Hercules Technology Growth Capital, Inc., is a business development company specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, seed, startups, early stage, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​